BioSpace News Archive

Medicure announced that pitavastatin magnesium (ZYPITAMAGTM) tablets are now available in retail pharmacies throughout the United States.

Aldeyra Therapeutics, Inc. presented the results of a randomized, double-masked, parallel-group Phase 2a dry eye disease clinical trial of topical ocular reproxalap at the Association for Research in Vision and Ophthalmology (ARVO) 2018 Annual Meeting.

Daiichi Sankyo and Takeda Pharmaceuticals to leverage FDA-approved test for clinical trials and drug development programs. [01-May-2018] Thermo Fisher Scientific Signs New Agreements to Expand Oncomine Dx Target Test Daiichi Sankyo and Takeda Pharmaceuticals to leverage FDA-approved test for clinical trials and dru

Ra Pharmaceuticals, Inc. announced that Doug Treco, Ph.D., President and Chief Executive Officer, will present at the Deutsche Bank 43rd Annual Health Care Conference on Tuesday, May 8, 2018 at 10:00 a.m. E.T.

Incyte Corporation reports 2018 first-quarter financial results, highlighting strong growth in total product-related revenue and providing a status update on the Company’s development portfolio.

Health2047 Inc. announced a $27.2 million follow-on investment from its founding partner, the American Medical Association (AMA).

Financing will allow continuation of lead program targeting a root cause of Alzheimer’s disease.

Initial Top-line Data Expected by the End of 2018

Transaction increases profit potential of aducanumab for Biogen and provides near-term capital to Neurimmune.

Inozyme Pharma is a biopharmaceutical company dedicated to developing treatments for rare and debilitating metabolic diseases